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Abstract p204 overexpression in retinoblastoma (Rb)3/3
mouse embryo fibroblasts or transfection of p204 mutated at
both Rb-binding sites confer growth advantages, resulting in a
significantly higher number of foci in a cell focus assay. To in-
vestigate the possibility that mutated p204 acquires malignant
transformation capability, NIH3T3 cells were stably transfected
with the expression vector pRcRSV204 double-mutant (p204dm)
harboring both the C-terminal deletion up to amino acid 568 and
the point mutation from glutamic acid to lysine at position 427,
and analyzed for markers typical of cell immortalization and
transformation. We detected a greater abundance of cell colonies
in soft agar with p204dm-expressing cells than vector control
cells. The p204dm-transfected cells also displayed two other char-
acteristics associated with malignant transformation, i.e. growth
under low-serum conditions and formation of tumors in athymic
nude mice. Moreover, their telomerase activity was significantly
higher than in the vector control cells. It would thus seem that
p204, devoid of functional Rb-binding motifs, can become
oncogenic. ß 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
To exert their antiproliferative activity, interferons (IFNs)
activate a family of transcription factors designated signal
transducers and activators of transcription and interferon reg-
ulatory factors, respectively, that translocate into the nucleus
and stimulate the expression of the IFN-stimulatable genes
[22,23]. One of the ¢rst downstream targets was identi¢ed as
the c-myc gene since its mRNA expression in hematopoietic
cells was suppressed at the transcriptional level by IFN-K [6].
Moreover, its disruption by ectopic expression of deregulated
c-myc partially suppressed the ability of IFN-K to arrest cells
speci¢cally in the G0/G1 phase [14]. The pRb protein was
then identi¢ed as another independent target of the IFN-K
signaling capable to complement the partial cell cycle arrest
mediated by c-myc inhibition through the suppression of its
phosphorylation [20]. The cyclin D3 and cdc25A genes have
since been shown to be primary targets of the IFN-K signaling
cascade. Suppression of cdc25A phosphatase is indeed the
main pathway for inhibition of cyclin E- and cyclin A-asso-
ciated kinase activities by IFN-K [6,24].
Of the several genes induced by IFNs, the mouse I¢200
genes [17,19] and their human homologues, myeloid nuclear
di¡erentiation antigen [2] and I¢16 [12], are transcriptionally
activated, both in vivo and in vitro. I¢204, a member of the
I¢200 gene cluster, encodes a 72 kDa phosphoprotein (p204)
that contains two partially conserved 200 amino acid seg-
ments, designated type a and type b, bearing an LXCXE
motif, known to be a potential site for binding to the retino-
blastoma (Rb)-family proteins [4]. Overexpression of p204 in
C2C12 myoblasts induced their fusion to myotubes suggesting
that it may be involved in muscle di¡erentiation [5]. In vivo
the I¢204 is constitutively expressed in myeloid cells and se-
lectively induced in the monocytes by IFNs, likely driving
their di¡erentiation to macrophages [7]. p204 overexpression
in mouse embryo ¢broblasts (MEF) retarded their prolifera-
tion, delayed G1 progression into S-phase and accumulated
cells with a DNA content equivalent to cells arrested in late
G1 [18]. These e¡ects on cell cycle progression were strictly
dependent on its association with the Rb protein [11]. Alto-
gether these studies demonstrated that p204^pRb interaction
is physiologically relevant to growth control and cell di¡er-
entiation, and changes in this pathway confer growth advan-
tages. Moreover, these ¢ndings suggested that p204 mutated
at the Rb-binding sites can acquire cell transformation capa-
bility, as shown for the mutated form of the PKR gene, an-
other IFN-inducible gene involved in growth control [16]. The
aim of the present study, therefore, was to investigate the
oncogenic activity of mutated p204 expression. For this pur-
pose, NIH3T3 cells were transfected with the expression con-
struct containing the mutated 204 cDNA and several aspects
associated with cell immortalization or malignant transforma-
tion, namely growth under low-serum conditions, ampli¢ca-
tion of telomerase activity (TERT), anchorage-independent
growth and the ability to form tumors in nude mice were
evaluated.
2. Materials and methods
2.1. Cell cultures and transfection
NIH3T3 cells were grown as monolayers in Dulbecco’s modi¢ed
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Eagle’s medium (DMEM; Gibco) supplemented with 10% donor calf
serum (DCS). Transfections were performed using Lipofectamine Plus
(Gibco) according to the manufacturer’s protocol. 2 Wg of expression
construct DNA pRcRSV204dm (for brevity p204dm), containing the
I¢204 cDNA mutated at both Rb-binding sites with an in-frame fu-
sion at the C-terminus with the hemagglutinin (HA) epitope as de-
scribed by Hertel et al. [10], were used for approximately 3U105 cells.
Stable transfectants were selected in the presence of 800 Wg/ml G418
in the culture medium. Pools of at least 100 colonies were harvested
and maintained in G418 selection. Expression of the exogenous pro-
tein was evaluated by Western blotting using the anti-HA-probe
monoclonal antibody (Boehringer). The morphology of the cells was
examined using an Olympus microscope.
2.2. Telomerase assay
Cells were washed in PBS, lysed, and TERT activity in the indi-
cated amount of total cell extracts was measured with the Telo-
TAGGG Telomerase PCR ELISAPLUS kit (Roche Molecular Bio-
chemicals) according to the manufacturer’s protocol [3]. The
telomerase PCR ELISA is an extension of the original described
TRAP protocol [13] and allows for the highly speci¢c ampli¢cation
of telomerase-mediated elongation products, combined with non-ra-
dioactive detection following an ELISA protocol. Each assay was
performed with an extract-free sample that contained only the reac-
tion mixture to detect PCR ampli¢cation of primer dimers, and one in
which extracts were treated with 1 U of RNase A as a control for
telomerase speci¢city. Only assays in which all control lanes showed
the expected results were included in this study.
2.3. Cell lysis and Western blotting
Cells were lysed in 3% SDS lysis bu¡er as previously described [11].
Insoluble material was removed by centrifugation. Protein concentra-
tion was determined by the Bio-Rad Dc Protein Assay (Bio-Rad Lab-
oratories). Total cell extracts were separated on SDS^8.5% polyacryl-
amide gel and transferred onto PVDF membrane (Amersham).
Membranes were blocked in blocking solution (10 mM Tris^HCl,
pH 7.5, 0.1 M NaCl, 0.1% Tween 20, 5% [w/v] non-fat dry milk)
and incubated in the same bu¡er with primary antibodies for 3 h at
room temperature, followed by a 1 h incubation with the appropriate
horseradish-peroxidase-conjugate secondary antibody and then de-
tected by enhanced chemoluminescence (Amersham). pRb was de-
tected using the Rb control antibody from Santa Cruz Biotechnology
(C-15/sc-50) at a dilution of 1:4000. The phosphorylation status of
pRb at Ser-780 was detected with the phospho-Rb (Ser-780) antibody
from Cell Signaling Technology at a dilution of 1:4000. Monoclonal
anti-actin antibodies (Boehringer) were used as internal control. Den-
sitometry was performed by scanning the radiographs and then ana-
lyzing the bands with the software Quantity One (Bio-Rad).
2.4. Soft agar and in vivo tumorigenicity assay
After transfection, cells were grown in the presence of G418 for 2.5
weeks. Pools of stable transfectants were harvested and aliquots were
added to 60-mm dishes in duplo containing 0.5% (w/v) SeaPlaque
agarose (FMC BioProducts) in complete culture medium on top of
a layer of 1% (w/v) SeaPlaque agarose. As a positive control, trans-
fectants with a construct containing an activated ras allele (Kirstein)
were included. Cells transfected with the empty vector pRcRSV were
included as negative controls. Aliquots of 1000, 10 000 and 100 000
cells were plated in duplo. After 16 days, 25 squares of 1 cm2 were
counted. Transfected cells were subcutaneously inoculated into the
right £ank of 6^8-week-old female athymic nude mice (Charles River
Laboratories) at the indicated concentrations. Each group consisted
of six animals. After inoculation, the incidence and growth of tumors
were evaluated at least twice a week. Neoplastic masses were mea-
sured with calipers in the two perpendicular diameters for at least 40
days. The mice were sacri¢ced when tumor growth started to interfere
with the health of the animals.
2.5. Expression analysis
Total cellular RNA was isolated by using the total RNA extraction
solution EUROzol (EUROclone). Semiquantitative reverse transcrip-
tion-polymerase chain reaction (RT-PCR) was carried out using 1 Wg
of total RNA as previously described [21]. Brie£y, total RNA was
reversed-transcribed into mRNA-dependent cDNA by using Moloney
murine leukemia virus RT (Ambion Inc.). 1-Wg aliquot for each sam-
ple served as non-RT control to control for genomic contamination in
subsequent PCR reactions. Equivalent amounts of cDNA were then
subjected to PCR analysis performed in a Hybaid PCR Express Ther-
mal cycler. The I¢204 primers (sense [5P-AAAGAGACAACCAA-
GAGCAATACACC-3P] and antisense [5P-GAATGTTAGAT-
GAAGCCGAAGATGAG-3P]) ampli¢ed a 567 bp fragment. The L-
actin primers (sense [5P-TGGAATCCTGTGGCATCCATGAAA-3P]
and antisense [5P-TAAAACGCAGCTCAGTAACAGTCCG-3P]) am-
pli¢ed a 348 bp fragment. For ampli¢cation of the DNA fragments, a
cycle number which was in the middle of the linear ampli¢cation
range (with a minimum of 25 and a maximum of 35 cycles) was
used. The reaction mixtures for each sample were added to a tube
containing 50 pmol each of the oligonucleotide primers for ampli¢ca-
tion of both I¢204 and L-actin. PCR was carried out as follows:
5-min denaturation step at 95‡C, followed by 30 cycles of 95‡C for
30 s, 58‡C for 30 s and 72‡C for 30 s, followed by 72‡C for 5 min to
allow for complete extension. Under these conditions, ampli¢cation of
I¢204 and L-actin product is in the exponential phase and the assay is
linear with respect to the amount of input RNA. Water controls in
which all components of the RT-PCR reaction were present, except
RNA, were also included. PCR products were electrophoresed on
1.5% agarose and stained with ethidium bromide for visualization.
3. Results and discussion
As a ¢rst attempt to verify whether the p204 mutant dis-
plays any oncogenic activity, NIH3T3 cells were ¢rst trans-
fected with the expression vector pRcRSV204 double mutant
(for brevity p204dm) harboring both the C-terminal deletion
up to amino acid 568 and the point mutation from glutamic
acid to lysine at position 427, which means that the protein is
devoid of any functional Rb-binding domain. Cells trans-
fected with an activated ras allele (226 cells) or the empty
vector (neo) were included as positive and negative controls.
We chose NIH3T3 cells because this cell line has been used
successfully to demonstrate the phenotypic e¡ects of a number
of proto-oncogenes [25]. After G418 selection for 2.5 weeks,
pooled populations of neomycin-resistant clones were har-
vested and used for further analysis. Expression of the trans-
fected mutant form was assessed by Western blotting by using
anti-HA monoclonal antibodies as previously described (data
not shown) [10].
Since growth in the absence of exogenous growth factors is
a characteristic of immortalized, transformed cells, the trans-
fected cells were tested for their ability to grow under low-
serum conditions (1 and 5% DCS). As can be seen in Fig. 1
(panel A), p204dm transfectants grew faster and to higher
densities compared to neo cells, which invariably displayed
lower growth rates and density. A similar growth pattern
was observed with 226 cells transformed by a c-Ki-ras gene.
Di¡erences in the numbers of cells when reaching con£uence
between the p204dm transfectants on one hand and the neo
cells on the other hand was mainly due to their ability to grow
to higher densities. Moreover, the morphologies of NIH3T3
C
Fig. 1. A: Growth curves of NIH3T3-transfected cells under low-serum conditions. Counts of the cells cultured in medium supplemented with
1% DCS (left panel), or 5% DCS (right panel) are shown. Each point represents the mean þ standard deviation of data obtained in three inde-
pendent experiments. B: Morphological changes in NIH3T3 expressing the empty vector (a), p204dm (b), and oncogenic ras (c). Cells were cul-
tured in 10% DCS^DMEM, allowed to grow until con£uence, and photographed with an inverted microscope.
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cells transfected with p204dm or oncogenic ras were clearly
di¡erent from those of the neo cells. After approximately 8^10
days, both p204dm and ras-transfected cells were more refrac-
tile, elongated, and piled up when they reached con£uence,
each other, whereas neo cells showed epithelial-like morphol-
ogy and formed elongated, rounded and neatly aligned struc-
tures (Fig. 1, panel B).
TERT has been demonstrated in a high percentage of ex-
tracts from most tumor types [13]. Cell lines, immortalized
either spontaneously or after transformation by oncogenic
viruses, such as simian virus 40 and human papillomavirus
types 16 or 18, are usually telomerase-positive [15]. Moreover,
TERT should be regarded as a biomarker of cell proliferation
rather than malignant transformation [1]. Since the above ex-
periments demonstrated that introduction of p204dm confers
growth characteristics typical of immortalized cells, neo,
p204dm and ras cells were compared for TERT activity. As
shown in Fig. 2, panel A, TERT was barely detectable in neo
cells, but signi¢cantly increased (10-fold) in p204dm cells. As
expected, ras cells displayed very high levels of TERT activity,
possibly associated with the growth properties of the Ki-ras
oncogene.
Altogether these results demonstrate that mutation at both
Rb-binding motifs wipes out the antiproliferative activity of
the I¢204 gene and endows it with growth-promoting activity.
We previously reported that as a consequence of p204 over-
expression and growth arrest, the Rb protein is almost com-
pletely converted to the rapidly migrating hypophosphory-
lated status [18]. To investigate the e¡ect of p204dm
overexpression on the Rb phosphorylation status, total cell
extracts were obtained from exponentially growing neo and
p204dm transfectants. As control, extracts from ras-trans-
formed cells were included. As shown in Fig. 2, panel B, a
signi¢cant increase of pRb phosphorylation (2.5-fold) was de-
tected in p204dm extracts, by using a phosphospeci¢c Rb
antibody, in comparison to the neo cells. As expected, ras-
transformed cells showed high levels of phosphorylated pRb
(four-fold induction). As a consequence of pRb phosphoryla-
tion, the E2F transcription factors are released and activate
the expression of the E2F-dependent genes required for
Fig. 2. A: E¡ect of p204dm overexpression on TERT detected by ELISA. Di¡erent amounts of total protein extracts from neo, p204dm and
ras cells pretreated or not with RNase were assayed for TERT using telomerase PCR ELISA assay. Absorbance values are reported as the
A450 nm reading against blank control (reference wavelength A690 nm). Each point represents the mean þ standard deviation of data obtained in
three independent experiments. B: E¡ect of p204dm overexpression on pRb phosphorylation. Total cell extracts (50 Wg) were size-fractionated
by 8.5% SDS^PAGE, transferred to PVDF membrane, and subjected to Western blotting for detection of pRb expression (pRb) and phosphor-
ylation (phospho-Rb). Actin immunodetection was performed as internal control.
Table 1
Microscopic counts and plating e⁄ciencies in soft agar assay
Construct 1U10 cells 1U104 cells 1U103 cells
Colonies/cm2 Plating e¡. (%)a Colonies/cm2 Plating e¡. (%) Colonies/cm2 Plating e¡. (%)
Neo 5 (4^6)b 0.005 2 (2^2) 0.02 ^ ^
p204dm 58 (52^64) 0.05 32 (31^33) 0.3 12 (10^14) 1.2
ras 76 (72^80) 0.05 49 (46^52) 0.4 21 (20^22) 2.1
aPlating e⁄ciency in the number of colonies U100 divided by the number of cells plated.
bThe values for the duplos are given separately between brackets.
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S-phase entry. Consistent with this hypothesis, we have pre-
viously shown that overexpression of wild type p204 but not
p204dm leads to a signi¢cant decrease of both proliferating
cell nuclear antigen (PCNA) and dihydrofolate reductase
(DHFR) protein levels, known to be regulated in a E2F de-
pendent manner [11].
Since anchorage-independent growth is one of the charac-
teristics of malignantly transformed cells, 1000, 10 000 and
100 000 transfected cells were plated in duplo onto soft agar
dishes. After 16 days, macroscopic colonies were present in all
dishes, including those of the negative controls and the ras-
transformed cells. Typical colony images are shown in Fig. 3.
The numbers of colonies and plating e⁄ciencies are displayed
in Table 1. When compared to neo cells, p204dm transfectants
yielded a number of colonies and a plating e⁄ciency signi¢-
cantly higher. As expected, the positive control (ras) clearly
demonstrated a better colony-forming e⁄ciency than any oth-
er transfectants. Microscopic examination also revealed that
the morphology of the p204dm colonies resembled that of ras
colonies (Fig. 3). These results indicated that overexpression
of p204dm in NIH3T3 cells enhanced the cellular proliferation
rate and conferred anchorage-independent characteristics.
To establish whether p204dm transfectants form tumors in
vivo, cells were inoculated at the indicated concentrations into
the right £ank of nude mice. Tumor size was examined twice a
week and palpable tumors were measured on two perpendic-
ular axes. Tumor volume was calculated by assuming spher-
ical growth, using the standard formula. All mice injected
with p204dm-transfected cells developed tumors in an inverse
dose^time-dependent manner within 10^25 days (Fig. 4, upper
panel). The mean tumor size in p204dm-transplanted nude
mice was approximately 4 cm3 at day 20 after transplantation
(with 106 cells/mouse); whereas, the mean tumor volume in
nude mice injected with neo cells (106 cells/mouse) only
reached 1 cm3 at day 35 after transplantation (Fig. 4, lower
panel). As expected, all the ras-inoculated mice bore large
tumors (2 cm3) as early as 2 weeks after inoculation. These
results indicate that p204dm not only promoted tumor
growth, but also enhanced the tumor incidence rate in nude
mice. After dissection, the tumors were analyzed by RT-PCR
for expression of the I¢204dm and the L-actin gene as control.
The results, presented in Fig. 5, showed comparable expres-
sion levels of the mutated 204 cDNA in the tumor extracts
derived from the p204dm group inoculated with the highest
cell concentration. By contrast, tumor extracts derived from
mice inoculated with 1U106 neo-cells were negative.
The results of this study demonstrate that expression of the
p204dm inactivated by mutation at both LXCXE motifs in-
creases cell proliferation along with TERT activity and an-
chorage independence. In addition, when p204dm-transfected
NIH3T3 were transplanted into nude mice, they also en-
hanced tumor size and incidence. It has been demonstrated
that Rb and the related p107 and p130 primarily inhibit
growth by targeting the E2F family transcription factors
[9]. We previously observed that the Rb protein is an essen-
tial mediator that links the IFN-inducible 204 gene to cell-
cycle regulation [8,11]. FACS analysis together with BrdU
incorporation and expression of DHFR and PCNA proteins
in Rb+/+ MEF transfected with wild type p204 demon-
strated indeed that interaction of p204 with Rb represses
E2F transcriptional activity. Although the e¡ect of p204
binding on pRb function remains to be explored, we can
conclude that the transdominant negative p204dm increases
pRb phosphorylation and relieves E2F to activate transcrip-
tion of target genes, such as DHFR, involved in cell growth
stimulation.
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